Clinical Trials Directory

Trials / Completed

CompletedNCT02503046

Estimation of Pentraxin3 and PGingivalis Levels in Patients With Knee Joint and Gum Diseases

Estimation of Pentraxin 3 and Porphyromonas Gingivalis Levels in Patients With Rheumatoid Arthritis and Periodontitis- An Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

Periodontitis and Rhematoid arthritis are chronic inflammatory diseases which share common risk factors The purpose of this study is to determine if Pentraxin 3 and Porphyromonas Gingivalis levels play an important role in the progression of both the diseases.

Detailed description

Periodontal disease progression might play a significant role in the severity and outcome of systemic diseases like rheumatoid arthritis. Pentraxin3 is a newly discovered inflammatory biomarker. It is a member of acute phase proteins and it has been observed from previous studies that plasma pentraxin3 levels have increased with increasing severity of cardiac and renal problems. Porphyromonas gingivalis proteinase is responsible for the epitope development in RF-Fc region These proteinases are important virulence factors which lead to degradation of host tissue. Porphyromonas gingivalis is also a key periodonto pathogen. Thus the aim of this study is to compare the plasma pentraxin3 and p.gingivalis levels in patients with periodontitis and rheumatoid arthritis.

Conditions

Interventions

TypeNameDescription
OTHEREstimation of Pentraxin35ml of blood to be collected from each subject, centrifuged, to separate the plasma for estimation of Pentraxin3 (Quantikine ELISA)
GENETICEstimation of P.Gingivalis levelsPooled plaque sample will be collected and sent for DNA Extraction by PCR for assessment of levels of PGingivalis

Timeline

Start date
2015-02-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2015-07-20
Last updated
2016-08-29

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02503046. Inclusion in this directory is not an endorsement.